A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

• Main Authors: Jane R. Schwebke (Author), Belvia A. Carter (Author), Arthur S. Waldbaum (Author), Kathy J. Agnew (Author), Jeremy R.A. Paull (Author), Clare F. Price (Author), Alex Castellarnau (Author), Philip McCloud (Author), George R. Kinghorn (Author)
• Format: Book
• Published: Elsevier, 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: The objective of the study was to confirm the efficacy and safety of Astodrimer 1% Gel to prevent recurrence of bacterial vaginosis. Study design: 864 women with a diagnosis of bacterial vaginosis and a history of recurrent bacterial vaginosis were enrolled in North America and first rece...